Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Nonsmall Cell Lung Cancer
Age: Between 22 - 80 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required